194 related articles for article (PubMed ID: 23391130)
1. Regional gray matter reduction correlates with subjective quality of life in schizophrenia.
Ubukata S; Miyata J; Yoshizumi M; Uwatoko T; Hirao K; Fujiwara H; Kawada R; Fujimoto S; Tanaka Y; Kubota M; Sasamoto A; Sawamoto N; Fukuyama H; Takahashi H; Murai T
J Psychiatr Res; 2013 Apr; 47(4):548-54. PubMed ID: 23391130
[TBL] [Abstract][Full Text] [Related]
2. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects.
Bergé D; Carmona S; Rovira M; Bulbena A; Salgado P; Vilarroya O
Acta Psychiatr Scand; 2011 Jun; 123(6):431-9. PubMed ID: 21054282
[TBL] [Abstract][Full Text] [Related]
3. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study.
Yamasue H; Iwanami A; Hirayasu Y; Yamada H; Abe O; Kuroki N; Fukuda R; Tsujii K; Aoki S; Ohtomo K; Kato N; Kasai K
Psychiatry Res; 2004 Sep; 131(3):195-207. PubMed ID: 15465289
[TBL] [Abstract][Full Text] [Related]
4. Gray matter volume differences specific to formal thought disorder in schizophrenia.
Horn H; Federspiel A; Wirth M; Müller TJ; Wiest R; Walther S; Strik W
Psychiatry Res; 2010 May; 182(2):183-6. PubMed ID: 20418073
[TBL] [Abstract][Full Text] [Related]
5. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
[TBL] [Abstract][Full Text] [Related]
6. Theory of mind and frontal lobe pathology in schizophrenia: a voxel-based morphometry study.
Hirao K; Miyata J; Fujiwara H; Yamada M; Namiki C; Shimizu M; Sawamoto N; Fukuyama H; Hayashi T; Murai T
Schizophr Res; 2008 Oct; 105(1-3):165-74. PubMed ID: 18774263
[TBL] [Abstract][Full Text] [Related]
7. Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study.
Wilke M; Kaufmann C; Grabner A; Pütz B; Wetter TC; Auer DP
Neuroimage; 2001 May; 13(5):814-24. PubMed ID: 11304078
[TBL] [Abstract][Full Text] [Related]
8. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
[TBL] [Abstract][Full Text] [Related]
9. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study.
Antonova E; Kumari V; Morris R; Halari R; Anilkumar A; Mehrotra R; Sharma T
Biol Psychiatry; 2005 Sep; 58(6):457-67. PubMed ID: 16039619
[TBL] [Abstract][Full Text] [Related]
10. Effects of menopause on brain structural changes in schizophrenia.
Fukuta H; Ito I; Tateno A; Nogami T; Taiji Y; Arakawa R; Suhara T; Asai K; Okubo Y
Psychiatry Clin Neurosci; 2013 Jan; 67(1):3-11. PubMed ID: 23331283
[TBL] [Abstract][Full Text] [Related]
11. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia.
Jayakumar PN; Venkatasubramanian G; Gangadhar BN; Janakiramaiah N; Keshavan MS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):587-91. PubMed ID: 15866362
[TBL] [Abstract][Full Text] [Related]
12. Alexithymia and regional gray matter alterations in schizophrenia.
Kubota M; Miyata J; Hirao K; Fujiwara H; Kawada R; Fujimoto S; Tanaka Y; Sasamoto A; Sawamoto N; Fukuyama H; Takahashi H; Murai T
Neurosci Res; 2011 Jun; 70(2):206-13. PubMed ID: 21300113
[TBL] [Abstract][Full Text] [Related]
13. Brain volume and dysexecutive behavior in schizophrenia.
Kawada R; Yoshizumi M; Hirao K; Fujiwara H; Miyata J; Shimizu M; Namiki C; Sawamoto N; Fukuyama H; Hayashi T; Murai T
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1255-60. PubMed ID: 19625009
[TBL] [Abstract][Full Text] [Related]
14. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia.
Wright IC; McGuire PK; Poline JB; Travere JM; Murray RM; Frith CD; Frackowiak RS; Friston KJ
Neuroimage; 1995 Dec; 2(4):244-52. PubMed ID: 9343609
[TBL] [Abstract][Full Text] [Related]
15. Social cognition and frontal lobe pathology in schizophrenia: a voxel-based morphometric study.
Yamada M; Hirao K; Namiki C; Hanakawa T; Fukuyama H; Hayashi T; Murai T
Neuroimage; 2007 Mar; 35(1):292-8. PubMed ID: 17240165
[TBL] [Abstract][Full Text] [Related]
16. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study.
Koutsouleris N; Gaser C; Jäger M; Bottlender R; Frodl T; Holzinger S; Schmitt GJ; Zetzsche T; Burgermeister B; Scheuerecker J; Born C; Reiser M; Möller HJ; Meisenzahl EM
Neuroimage; 2008 Feb; 39(4):1600-12. PubMed ID: 18054834
[TBL] [Abstract][Full Text] [Related]
17. Mr morphometry analysis of grey matter volume reduction in schizophrenia: association with hallucinations.
Neckelmann G; Specht K; Lund A; Ersland L; Smievoll AI; Neckelmann D; Hugdahl K
Int J Neurosci; 2006 Jan; 116(1):9-23. PubMed ID: 16318996
[TBL] [Abstract][Full Text] [Related]
18. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.
Mané A; Falcon C; Mateos JJ; Fernandez-Egea E; Horga G; Lomeña F; Bargalló N; Prats-Galino A; Bernardo M; Parellada E
Schizophr Res; 2009 Oct; 114(1-3):136-43. PubMed ID: 19683418
[TBL] [Abstract][Full Text] [Related]
19. Social impairment in schizophrenia revealed by Autism-Spectrum Quotient correlated with gray matter reduction.
Sasamoto A; Miyata J; Hirao K; Fujiwara H; Kawada R; Fujimoto S; Tanaka Y; Kubota M; Sawamoto N; Fukuyama H; Takahashi H; Murai T
Soc Neurosci; 2011; 6(5-6):548-58. PubMed ID: 21943127
[TBL] [Abstract][Full Text] [Related]
20. Regional gray matter reduction and theory of mind deficit in the early phase of schizophrenia: a voxel-based morphometric study.
Herold R; Feldmann A; Simon M; Tényi T; Kövér F; Nagy F; Varga E; Fekete S
Acta Psychiatr Scand; 2009 Mar; 119(3):199-208. PubMed ID: 19016669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
